Tracey L. McCain

Filings by Tracey L. McCain span 2 companies, the busiest being Blueprint Medicines Corp and Kiniksa Pharmaceuticals International, plc. The record holds 15 filings, for trades running from 23 September 2021 to 17 July 2025.

Sales make up the whole of the open-market record (4 sales, €1.1M). Outside the open market, there are 5 share grants and 6 option exercises. Since January 2025: no purchases and 1 sale on the market.

The record was last updated on 21 July 2025 with a share grant in Blueprint Medicines Corp. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.